7d4153fd personal page - To The Moon

7d4153fd

No personal profile

2Follow

1Followers

0Topic

0Badge

2022-01-03

Not bad

These are the top 3 stocks to watch in 2022: Analyst

2022-01-03

Nice

China Evergrande shares to halt trading

2022-01-03

Wow

2022 Could Be a Make-or-Break Year for Lucid Stock

2022-01-03

Fantastic

Sorry, the original content has been removed

2021-12-31

Unpredictable

Teva, Units Held Liable for Fueling N.Y. Opioid Crisis

2021-12-31

Amazing

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4102463477609770","uuid":"4102463477609770","gmtCreate":1639361543397,"gmtModify":1639370757261,"name":"7d4153fd","pinyin":"7d4153fd","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":2,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9001103315,"gmtCreate":1641179543862,"gmtModify":1676533579944,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102463477609770","authorIdStr":"4102463477609770"},"themes":[],"htmlText":"Not bad","listText":"Not bad","text":"Not bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001103315","repostId":"2200443647","repostType":4,"repost":{"id":"2200443647","kind":"news","pubTimestamp":1641175008,"share":"https://ttm.financial/m/news/2200443647?lang=en_US&edition=fundamental","pubTime":"2022-01-03 09:56","market":"us","language":"en","title":"These are the top 3 stocks to watch in 2022: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2200443647","media":"Yahoo Finance","summary":"Investors should keep an eye out for casino and real estate stocks next year, according to Gerber Ka","content":"<html><head></head><body><p>Investors should keep an eye out for casino and real estate stocks next year, according to Gerber Kawasaki Wealth &amp; Investment Management CEO Ross Gerber.</p><p>MGM (MGM), Lennar (LEN), and Tesla (TSLA) were selected as the top three stocks poised to rise in 2022 in Gerber’s preview. He joined Yahoo Finance Live on Thursday to discuss which stocks should perform best next year.</p><p>“MGM is a long-term holding of ours and we&#39;ve been adding to it on the weakness because of Omicron,” Gerber said. “And we absolutely believe this is the endgame for Corona, this winter being sort of one of the tougher winters again. But as each winter rolls on, this will become much more normal and much less disruptive.”</p><p>MGM Resorts International, a giant in the hospitality and entertainment industry, specializes in casinos, hotels, and resorts. As the global outlook continues to improve and the economy adjusts to the new realities concerning COVID, Gerber noted, the hospitality sector could stand to benefit greatly.</p><p>The prospect of interest rate hikes in 2022 looms over the economic picture for next year and has dampened some analysts’ expectations for stock market growth. “The probability of a 10% correction in the near term or over the next 12 months is elevated,” Bank of America’s (BAC) U.S. stock and quantitative strategy chief Savita Subramanian told Bloomberg earlier this month.</p><p>Gerber, who expressed doubt that all three Fed rate hikes would come in 2022, had a more optimistic disposition.</p><p>“We actually don&#39;t think the Fed will actually hit their three rate hikes next year, we&#39;ll see,” he said. “But if it does happen, it won&#39;t be till the end of the year, and so housing is a supply and demand imbalance on a massive scale. And home builders like Lennar, especially Lennar, which is a really large, established home builder in multiple regions, are just benefiting from this enormous demand. So every house they&#39;re building, the profits just go up every month because prices keep going up.”</p><p>Lennar, a Florida-based home construction company, has suffered recently from supply chain disruptions related to the pandemic. However, industry experts expect many of these challenges within the housing market to be overcome next year. Research and Markets reported that the U.S. construction industry is expected to grow by 3.7% in 2022.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8038b8b290f38bd18329917959e39f73\" tg-width=\"6000\" tg-height=\"4000\" width=\"100%\" height=\"auto\"/><span>NEWARK, CALIFORNIA - DECEMBER 15: A worker makes repairs to a home under construction at the Lennar Bridgeway home development on December 15, 2021 in Newark, California. Homebuilder Lennar will report fourth quarter earnings today after the closing bell. (Photo by Justin Sullivan/Getty Images)Justin Sullivan via Getty Images</span></p><p>Throughout most of the year, the housing market has remained hot. Similar to other industries, like electronics, housing has faced supply bottlenecks and labor shortages which have restricted supply in the face of rising demand. The Federal Housing Finance Agency reported that housing prices grew 18.5% through 2021 Q3 compared to a year ago, culminating in the largest annual increase in the agency’s House Price Index.</p><p><img src=\"https://static.tigerbbs.com/125965aa9230614070fe2f36dbe141ba\" tg-width=\"819\" tg-height=\"688\" width=\"100%\" height=\"auto\"/></p><p>Tesla was Gerber’s last recommendation, and his number one pick for investors in 2022. He had some bold predictions for the EV maker in his interview with Yahoo Finance Live.</p><p>“I think over the next decade, Tesla will be the most consequential company in the history of business,” Gerber said. “I think in 12 months, we&#39;re going to see amazing breakthroughs in AI and technology. And what Elon has done yet, we don&#39;t know, you want to own stock in this future. So with robotics, AI, and the dominance in the EV and climate space, Tesla is the best stock of all time.”</p><p>Tesla certainly rewarded bullish investors in 2021. This year, Tesla stock has gained 56%, more than double the S&amp;P 500’s 27% rise.</p><p>Even so, challenges remain. The company recalled nearly half a million of its Model 3 and Model S over safety issues concerning the cars’ rear view cameras and trunk. Industry experts have raised concerns regarding the sustainability of Tesla’s high market share in the EV market, as well as the possible emergence of competitors.</p><p>Gerber cautioned investors not to be too concerned about the recalls. Recalls are relatively normal for car companies, and Tesla’s main strengths lay outside of their automobile services, anyway, he added.</p><p>“Tesla is a better AI technology company than a car company, as we&#39;ve all learned over the last 10 years,” he said. “They build cars, but they&#39;re basically building an iPhone on wheels. And so the entire infrastructure that they&#39;ve been building around service, for example, has been a big challenge for them. They&#39;ve innovated some amazing things like mobile service.”</p><p>Overall, stocks stayed flat on the final trading day of 2021, giving this year’s Santa Claus Rally a rather muted finish. The S&amp;P 500 reached an intraday high Thursday but fell in the afternoon. This year, the index reached a record high every month, a feat achieved only once before, in 2014.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These are the top 3 stocks to watch in 2022: Analyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese are the top 3 stocks to watch in 2022: Analyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 09:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/top-3-stocks-to-watch-in-2022-analyst-171050141.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors should keep an eye out for casino and real estate stocks next year, according to Gerber Kawasaki Wealth & Investment Management CEO Ross Gerber.MGM (MGM), Lennar (LEN), and Tesla (TSLA) were...</p>\n\n<a href=\"https://finance.yahoo.com/news/top-3-stocks-to-watch-in-2022-analyst-171050141.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4527":"明星科技股","BK4553":"喜马拉雅资本持仓","LEN":"莱纳建筑公司","BAC":"美国银行","BK4099":"汽车制造商","BK4534":"瑞士信贷持仓","BK4555":"新能源车","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4150":"赌场与赌博","BK4504":"桥水持仓","MGM":"美高梅","BK4559":"巴菲特持仓","BK4088":"住宅建筑","BK4550":"红杉资本持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4207":"综合性银行","TSLA":"特斯拉","BK4561":"索罗斯持仓"},"source_url":"https://finance.yahoo.com/news/top-3-stocks-to-watch-in-2022-analyst-171050141.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200443647","content_text":"Investors should keep an eye out for casino and real estate stocks next year, according to Gerber Kawasaki Wealth & Investment Management CEO Ross Gerber.MGM (MGM), Lennar (LEN), and Tesla (TSLA) were selected as the top three stocks poised to rise in 2022 in Gerber’s preview. He joined Yahoo Finance Live on Thursday to discuss which stocks should perform best next year.“MGM is a long-term holding of ours and we've been adding to it on the weakness because of Omicron,” Gerber said. “And we absolutely believe this is the endgame for Corona, this winter being sort of one of the tougher winters again. But as each winter rolls on, this will become much more normal and much less disruptive.”MGM Resorts International, a giant in the hospitality and entertainment industry, specializes in casinos, hotels, and resorts. As the global outlook continues to improve and the economy adjusts to the new realities concerning COVID, Gerber noted, the hospitality sector could stand to benefit greatly.The prospect of interest rate hikes in 2022 looms over the economic picture for next year and has dampened some analysts’ expectations for stock market growth. “The probability of a 10% correction in the near term or over the next 12 months is elevated,” Bank of America’s (BAC) U.S. stock and quantitative strategy chief Savita Subramanian told Bloomberg earlier this month.Gerber, who expressed doubt that all three Fed rate hikes would come in 2022, had a more optimistic disposition.“We actually don't think the Fed will actually hit their three rate hikes next year, we'll see,” he said. “But if it does happen, it won't be till the end of the year, and so housing is a supply and demand imbalance on a massive scale. And home builders like Lennar, especially Lennar, which is a really large, established home builder in multiple regions, are just benefiting from this enormous demand. So every house they're building, the profits just go up every month because prices keep going up.”Lennar, a Florida-based home construction company, has suffered recently from supply chain disruptions related to the pandemic. However, industry experts expect many of these challenges within the housing market to be overcome next year. Research and Markets reported that the U.S. construction industry is expected to grow by 3.7% in 2022.NEWARK, CALIFORNIA - DECEMBER 15: A worker makes repairs to a home under construction at the Lennar Bridgeway home development on December 15, 2021 in Newark, California. Homebuilder Lennar will report fourth quarter earnings today after the closing bell. (Photo by Justin Sullivan/Getty Images)Justin Sullivan via Getty ImagesThroughout most of the year, the housing market has remained hot. Similar to other industries, like electronics, housing has faced supply bottlenecks and labor shortages which have restricted supply in the face of rising demand. The Federal Housing Finance Agency reported that housing prices grew 18.5% through 2021 Q3 compared to a year ago, culminating in the largest annual increase in the agency’s House Price Index.Tesla was Gerber’s last recommendation, and his number one pick for investors in 2022. He had some bold predictions for the EV maker in his interview with Yahoo Finance Live.“I think over the next decade, Tesla will be the most consequential company in the history of business,” Gerber said. “I think in 12 months, we're going to see amazing breakthroughs in AI and technology. And what Elon has done yet, we don't know, you want to own stock in this future. So with robotics, AI, and the dominance in the EV and climate space, Tesla is the best stock of all time.”Tesla certainly rewarded bullish investors in 2021. This year, Tesla stock has gained 56%, more than double the S&P 500’s 27% rise.Even so, challenges remain. The company recalled nearly half a million of its Model 3 and Model S over safety issues concerning the cars’ rear view cameras and trunk. Industry experts have raised concerns regarding the sustainability of Tesla’s high market share in the EV market, as well as the possible emergence of competitors.Gerber cautioned investors not to be too concerned about the recalls. Recalls are relatively normal for car companies, and Tesla’s main strengths lay outside of their automobile services, anyway, he added.“Tesla is a better AI technology company than a car company, as we've all learned over the last 10 years,” he said. “They build cars, but they're basically building an iPhone on wheels. And so the entire infrastructure that they've been building around service, for example, has been a big challenge for them. They've innovated some amazing things like mobile service.”Overall, stocks stayed flat on the final trading day of 2021, giving this year’s Santa Claus Rally a rather muted finish. The S&P 500 reached an intraday high Thursday but fell in the afternoon. This year, the index reached a record high every month, a feat achieved only once before, in 2014.","news_type":1,"symbols_score_info":{"BAC":1,"TSLA":1,"MGM":1,"LEN":0.9}},"isVote":1,"tweetType":1,"viewCount":1859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001103975,"gmtCreate":1641179529100,"gmtModify":1676533579951,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102463477609770","authorIdStr":"4102463477609770"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001103975","repostId":"2200283644","repostType":4,"repost":{"id":"2200283644","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641175222,"share":"https://ttm.financial/m/news/2200283644?lang=en_US&edition=fundamental","pubTime":"2022-01-03 10:00","market":"us","language":"en","title":"China Evergrande shares to halt trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2200283644","media":"Reuters","summary":"HONG KONG (Reuters) - China Evergrande Group said its shares will be suspended from trading on Monda","content":"<html><head></head><body><p>HONG KONG (Reuters) - China Evergrande Group said its shares will be suspended from trading on Monday, without giving any reason.</p><p>The embattled property developer has more than $300 billion in liabilities and is scrambling to raise cash by selling assets and shares to repay suppliers and creditors.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Evergrande shares to halt trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Evergrande shares to halt trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-03 10:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>HONG KONG (Reuters) - China Evergrande Group said its shares will be suspended from trading on Monday, without giving any reason.</p><p>The embattled property developer has more than $300 billion in liabilities and is scrambling to raise cash by selling assets and shares to repay suppliers and creditors.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4124":"机动车零配件与设备","BK1240":"房地产开发","BK1598":"恒大概念","BK1507":"粤港澳大湾区","BK1555":"内房股","03333":"中国恒大"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200283644","content_text":"HONG KONG (Reuters) - China Evergrande Group said its shares will be suspended from trading on Monday, without giving any reason.The embattled property developer has more than $300 billion in liabilities and is scrambling to raise cash by selling assets and shares to repay suppliers and creditors.","news_type":1,"symbols_score_info":{"03333":1}},"isVote":1,"tweetType":1,"viewCount":1507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001103090,"gmtCreate":1641179507836,"gmtModify":1676533579944,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102463477609770","authorIdStr":"4102463477609770"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001103090","repostId":"1135044066","repostType":4,"repost":{"id":"1135044066","kind":"news","pubTimestamp":1641178156,"share":"https://ttm.financial/m/news/1135044066?lang=en_US&edition=fundamental","pubTime":"2022-01-03 10:49","market":"us","language":"en","title":"2022 Could Be a Make-or-Break Year for Lucid Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1135044066","media":"InvestorPlace","summary":"LCID stock is likely to remain volatile as the EV maker attempts to become a key contender","content":"<div>\n<p>Electric vehicle startup Lucid Group(NASDAQ:LCID) has seen some wild swings in recent months. Between mid-October and mid-November, LCID stock more than doubled in price before quickly reversing and ...</p>\n\n<a href=\"https://investorplace.com/2021/12/2022-could-be-a-make-or-break-year-for-lcid-stock/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2022 Could Be a Make-or-Break Year for Lucid Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2022 Could Be a Make-or-Break Year for Lucid Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 10:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/2022-could-be-a-make-or-break-year-for-lcid-stock/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Electric vehicle startup Lucid Group(NASDAQ:LCID) has seen some wild swings in recent months. Between mid-October and mid-November, LCID stock more than doubled in price before quickly reversing and ...</p>\n\n<a href=\"https://investorplace.com/2021/12/2022-could-be-a-make-or-break-year-for-lcid-stock/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc"},"source_url":"https://investorplace.com/2021/12/2022-could-be-a-make-or-break-year-for-lcid-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135044066","content_text":"Electric vehicle startup Lucid Group(NASDAQ:LCID) has seen some wild swings in recent months. Between mid-October and mid-November, LCID stock more than doubled in price before quickly reversing and falling more than 30% into its early December low.The sell-off included an 18% single-day drop on news the U.S. Securities and Exchange Commission was investigating Lucid’s special purpose acquisition company merger.Yet, many believe the company is about to become akey contender in the EV race. It has already started mass production, made initial customer deliveries and is expanding its manufacturing plant.So, as we head into the new year, investors are wondering what’s in store for LCID stock.EV SPACs Under PressureLucid Group made its public debut in late July via a reverse merger with SPAC Churchill Capital Corp IV. Amid the growing EV hype, the initial public offering raised an impressive $4.4 billion in cash.However, in recent months, the SEC has been investigating the SPAC mergers of a number of EV companies. In addition to Lucid, other companies caught in the SEC’s crosshairs include Lordstown Motors(NASDAQ:RIDE),Canoo(NASDAQ:GOEV) and Nikola(NASDAQ:NKLA).As a result, shares of these EV startups have come under pressure in recent weeks. December was also a down month for a number of exchange-traded funds that focus on SPACs. For instance, the Defiance Next Gen SPAC Derived ETF(NYSEARCA:SPAK) lost about 9% for the month.Despite the recent slump, LCID stock has returned more than 50% since going public in late July. And the EV market represents a huge growth opportunity.According toBloombergNEF, the number of EVs sold worldwide this year is expected to nearly double from 2020, hitting a record 6.3 million units. Looking ahead, the Organization of Petroleum Exporting Countries predicted in its 2045 oil outlook that there will be close to 500 million EVs on the road by 2045, accounting for nearly a fifth of the global fleet.Lucid Faces Several ChallengesLCID reported third-quarter results on Nov 15. Revenue came in at $232,000, down 30.5% from the prior-year quarter, while the net loss totaled $524.4 million. However, the company did end the quarter with a nice cash position of $4.8 billion.As of mid-November, Lucid had received over 17,000 reservations for its Lucid Air sedan. To meet demand, management is expanding production capacity at its Arizona plant by adding 2.85 million square feet of space. Lucid aims to manufacture 20,000 EVs next yearand a total of90,000 vehicles by the end of 2023, including new models such as its first SUV, the Gravity.Although investors have been excited about Lucid’s growth prospects, the EV space is highly competitive. In addition to EV darlings like Tesla(NASDAQ:TSLA) and Nio(NYSE:NIO), legacy automakers such as Ford Motor(NYSE:F) and General Motors(NYSE:GM) are making significant inroads in the EV space.Given the recent SEC investigation, as well as the lack of a clear path to profitability, Lucid faces several challenges. The transition period from prototypes to commercial production is typically rife with risks, which could lead to volatility in LCID stock.Thus, a pullback toward $35 or even below could make a better entry point for growth investors.2 Alternative Ways to Invest in LCID StockFor investors who are interested in LCID stock but looking for a way to reduce risk, allow me to pose two alternative strategies.First, there are a number of ETFs that provide exposure to LCID stock, including the iShares MSCI USA Size Factor ETF(NYSEARCA:SIZE),VanEck Low Carbon Energy ETF(NYSEARCA:SMOG) and Vanguard Mid-Cap Value Index Fund ETF Shares(NYSEARCA:VOE).Those readers who are experienced in options could also consider selling cash-secured puts. This strategy may be appropriate if you are slightly bullish or neutral on LCID stock at this time.Selling cash-secured put options generates income as the seller receives a premium. As I write, LCID stock is trading around $38.30. If you sold the $38 strike put that expires on Jan. 21, you could collect about $2.65 in premium. Therefore, the maximum return for the seller on the day of expiry would be $265, excluding trading commissions and costs, if the option expires worthless.If the put option is in the money (meaning LCID stock is lower than the strike price of $38) any time before or at expiration on Jan. 21, this put option can be assigned. The seller would then be obligated to buy 100 shares of LCID stock at the put option strike price of $38 for a total of $3,800 per contract. In that case, the trader ends up owning LCID stock for $35.35 per share, about 8% below the current price.If the put seller gets assigned shares, the maximum risk is similar to that of stock ownership (the stock could theoretically fall to zero) but partially offset by the premium received ($265).The Bottom Line on LCID StockAs I mentioned above,many believe Lucid will become a top contender in the EV race. Its Lucid Air was named the 2022 MotorTrend Car of the Year, an honor bestowed on Tesla’s Model S in 2012.In another sign that bodes well for the EV maker’s exposure and legitimacy, LCID stock wasadded to the Nasdaq 100 index on Dec. 13. And the company recently raised $2.6 billion from a “greenshoeoption” under the convertible senior notes offering, increasing liquidity.On the one hand, Lucid has plans for a broad product range from luxury SUVs to cheaper EVs and the cash buffer to carry out those plans. On the other hand, it faces commercial risks such as production delays, semiconductor shortage-related disruptions and slowing economic growth.Therefore, investors should keep an eye on the sentiment and consider buying LCID stock on a dip or employing an alternative strategy like selling puts or purchasing an ETF to gain exposure to the EV maker.","news_type":1,"symbols_score_info":{"LCID":0}},"isVote":1,"tweetType":1,"viewCount":3019,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001109482,"gmtCreate":1641179490977,"gmtModify":1676533579936,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102463477609770","authorIdStr":"4102463477609770"},"themes":[],"htmlText":"Fantastic&nbsp;","listText":"Fantastic&nbsp;","text":"Fantastic","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001109482","repostId":"2200403714","repostType":4,"isVote":1,"tweetType":1,"viewCount":1789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003158743,"gmtCreate":1640913705849,"gmtModify":1676533554094,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102463477609770","authorIdStr":"4102463477609770"},"themes":[],"htmlText":"Unpredictable&nbsp;","listText":"Unpredictable&nbsp;","text":"Unpredictable","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003158743","repostId":"1175474428","repostType":4,"repost":{"id":"1175474428","kind":"news","pubTimestamp":1640912453,"share":"https://ttm.financial/m/news/1175474428?lang=en_US&edition=fundamental","pubTime":"2021-12-31 09:00","market":"us","language":"en","title":"Teva, Units Held Liable for Fueling N.Y. Opioid Crisis","url":"https://stock-news.laohu8.com/highlight/detail?id=1175474428","media":"Bloomberg","summary":"(Bloomberg) -- New York jurors concluded Teva Pharmaceutical Industries and some of its units helped","content":"<html><head></head><body><p>(Bloomberg) -- New York jurors concluded Teva Pharmaceutical Industries and some of its units helped create a public-health crisis through their marketing and distribution of opioid painkillers across the state, in the pharma industry’s latest loss in the sprawling litigation over the highly addictive drugs.</p><p>The Israel-based firm now faces potentially billions of dollars in compensation claims from the state and two Long Island counties accusing Teva executives of flooding their areas with more than a billion opioids pills over nearly a decade and using misleading tactics to sell them.</p><p>Teva’s American depository receipts fell as much as 5.3% in New York trading, the most intraday since Nov. 3.</p><p>“Teva Pharmaceuticals strongly disagrees with today’s outcome and will prepare for a swift appeal,” Kelley Dougherty, a U.S.-based spokeswoman for Teva, said in an emailed statement. The state and local governments “presented no evidence of medically unnecessary prescriptions, suspicious or diverted orders, no evidence of oversupply by the defendants” and also failed to show “any harm to the public in the state,” she said.</p><p>Judge Jerry Garguilo will decide later how much the state and counties should get to beef up treatment and social-service budgets depleted by the U.S. opioid crisis, which has killed more than 500,000 Americans over the last two decades. A hearing on the compensation issue hasn’t yet been set.</p><p><b>‘Death and Destruction’</b></p><p>Jurors found Teva itself was 30% liable for harm created by its opioid marketing in Suffolk and Nassau counties while it was 40% liable for the problems across the whole state. Its units’ percentages of fault made up the remainder of 100%, according to the verdict form.</p><p>“A jury has found an opioid manufacturer responsible for the death and destruction they inflicted on the American people,” New York Attorney General Letitia James said in an emailed statement. “Teva Pharmaceuticals USA and others misled the American people about the true dangers of opioids.”</p><p>Jayne Conroy, one of the counties’ lawyers, noted the jurors deliberated for more than a week before finding against Teva and its units. She said the panel properly found “manufacturer Teva and distributor Anda cannot break the law for profit and cause deadly harm to our communities.”</p><p>Lawyers for Teva and Anda on Thursday asked Garguilo to throw out the verdict, saying the state and counties didn’t prove the companies created a public nuisance. They also pointed to the inconsistency in the percentage of fault Teva faces in the verdicts on behalf of the counties and the state as warranting a new trial.</p><p><b>Second Verdict</b></p><p>Thursday’s jury verdict is the second in the burgeoning four-year opioid litigation. Municipalities accuse opioid makers, distributors and sellers of downplaying the painkillers’ addiction risks and sacrificing patient safety for billions in profits. They also blame them for contributing to the deaths of more than 500,000 Americans in the opioid epidemic over the last two decades.</p><p>The state-court jury found Teva and subsidiaries including Anda Inc. and Cephalon Inc. created a so-called “public nuisance” by marketing the opioid-based drugs in a misleading manner and not properly monitoring suspicious shipments of the highly addictive painkillers. The panel concluded the marketing “contributed to, or maintained a substantial and unreasonable interference with a public right that amounts to a public nuisance,” according to the verdict form.</p><p>The trial over the governments’ claims began in June with more than 30 companies as defendants. By the end, only Teva and its units, including Cephalon Inc., Actavis Pharma and Watson Laboratories Inc., were left to face the six-person jury. That’s because other opioid makers, including Johnson &amp; Johnson and Endo International Plc, drug distributors such as McKesson Corp. and Cardinal Health Inc. drugstore chains like Rite Aid Inc. and Walgreens Boots Alliance Inc., settled to get out of the trial.</p><p>The six-month trial, held in Suffolk County on Long Island, featured internal sales-conference videos produced by Cephalon that the governments alleged showed the company pushed opioid sales to beef up bonuses and put profit over consumers’ safety.</p><p><b>Dr. Evil</b></p><p>The panel saw a 2006 video based on a scene from the 1992 film “A Few Good Men,” that the Teva subsidiary used at a sales conference to promote its opioid-based drug, Fentora.</p><p>Dressed in a Marine uniform, Roy Craig, a Cephalon sales manager, portrays Jack Nicholson’s character in the movie. “I have neither the time nor the inclination to explain ourselves to people who rise and sleep under the very blanket of revenue we provide and then question the manner in which we provide it,” Craig says on the video.</p><p>Lawyers for the governments also showed jurors a dubbed parody of the 1997 “Austin Powers, International Man of Mystery” movie in which the villain, Dr. Evil, portrays a Cephalon sales executive leading a Fentora marketing meeting.</p><p>Dr. Evil -- played by actor Michael Myers -- ejects subordinate Will Ferrell into a fiery pit over his unhappiness with the new painkiller’s packaging and comes up with several aggressive marketing ideas. The video was made for a 2007 annual sales conference.</p><p>The case is In Re Opioid Litigation, Index no. 40000/2017, Supreme Court of New York, Suffolk County.</p></body></html>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teva, Units Held Liable for Fueling N.Y. Opioid Crisis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeva, Units Held Liable for Fueling N.Y. Opioid Crisis\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pharmaceutical-company-held-liable-fuelling-182732417.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- New York jurors concluded Teva Pharmaceutical Industries and some of its units helped create a public-health crisis through their marketing and distribution of opioid painkillers across...</p>\n\n<a href=\"https://finance.yahoo.com/news/pharmaceutical-company-held-liable-fuelling-182732417.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TEVA":"梯瓦制药"},"source_url":"https://finance.yahoo.com/news/pharmaceutical-company-held-liable-fuelling-182732417.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175474428","content_text":"(Bloomberg) -- New York jurors concluded Teva Pharmaceutical Industries and some of its units helped create a public-health crisis through their marketing and distribution of opioid painkillers across the state, in the pharma industry’s latest loss in the sprawling litigation over the highly addictive drugs.The Israel-based firm now faces potentially billions of dollars in compensation claims from the state and two Long Island counties accusing Teva executives of flooding their areas with more than a billion opioids pills over nearly a decade and using misleading tactics to sell them.Teva’s American depository receipts fell as much as 5.3% in New York trading, the most intraday since Nov. 3.“Teva Pharmaceuticals strongly disagrees with today’s outcome and will prepare for a swift appeal,” Kelley Dougherty, a U.S.-based spokeswoman for Teva, said in an emailed statement. The state and local governments “presented no evidence of medically unnecessary prescriptions, suspicious or diverted orders, no evidence of oversupply by the defendants” and also failed to show “any harm to the public in the state,” she said.Judge Jerry Garguilo will decide later how much the state and counties should get to beef up treatment and social-service budgets depleted by the U.S. opioid crisis, which has killed more than 500,000 Americans over the last two decades. A hearing on the compensation issue hasn’t yet been set.‘Death and Destruction’Jurors found Teva itself was 30% liable for harm created by its opioid marketing in Suffolk and Nassau counties while it was 40% liable for the problems across the whole state. Its units’ percentages of fault made up the remainder of 100%, according to the verdict form.“A jury has found an opioid manufacturer responsible for the death and destruction they inflicted on the American people,” New York Attorney General Letitia James said in an emailed statement. “Teva Pharmaceuticals USA and others misled the American people about the true dangers of opioids.”Jayne Conroy, one of the counties’ lawyers, noted the jurors deliberated for more than a week before finding against Teva and its units. She said the panel properly found “manufacturer Teva and distributor Anda cannot break the law for profit and cause deadly harm to our communities.”Lawyers for Teva and Anda on Thursday asked Garguilo to throw out the verdict, saying the state and counties didn’t prove the companies created a public nuisance. They also pointed to the inconsistency in the percentage of fault Teva faces in the verdicts on behalf of the counties and the state as warranting a new trial.Second VerdictThursday’s jury verdict is the second in the burgeoning four-year opioid litigation. Municipalities accuse opioid makers, distributors and sellers of downplaying the painkillers’ addiction risks and sacrificing patient safety for billions in profits. They also blame them for contributing to the deaths of more than 500,000 Americans in the opioid epidemic over the last two decades.The state-court jury found Teva and subsidiaries including Anda Inc. and Cephalon Inc. created a so-called “public nuisance” by marketing the opioid-based drugs in a misleading manner and not properly monitoring suspicious shipments of the highly addictive painkillers. The panel concluded the marketing “contributed to, or maintained a substantial and unreasonable interference with a public right that amounts to a public nuisance,” according to the verdict form.The trial over the governments’ claims began in June with more than 30 companies as defendants. By the end, only Teva and its units, including Cephalon Inc., Actavis Pharma and Watson Laboratories Inc., were left to face the six-person jury. That’s because other opioid makers, including Johnson & Johnson and Endo International Plc, drug distributors such as McKesson Corp. and Cardinal Health Inc. drugstore chains like Rite Aid Inc. and Walgreens Boots Alliance Inc., settled to get out of the trial.The six-month trial, held in Suffolk County on Long Island, featured internal sales-conference videos produced by Cephalon that the governments alleged showed the company pushed opioid sales to beef up bonuses and put profit over consumers’ safety.Dr. EvilThe panel saw a 2006 video based on a scene from the 1992 film “A Few Good Men,” that the Teva subsidiary used at a sales conference to promote its opioid-based drug, Fentora.Dressed in a Marine uniform, Roy Craig, a Cephalon sales manager, portrays Jack Nicholson’s character in the movie. “I have neither the time nor the inclination to explain ourselves to people who rise and sleep under the very blanket of revenue we provide and then question the manner in which we provide it,” Craig says on the video.Lawyers for the governments also showed jurors a dubbed parody of the 1997 “Austin Powers, International Man of Mystery” movie in which the villain, Dr. Evil, portrays a Cephalon sales executive leading a Fentora marketing meeting.Dr. Evil -- played by actor Michael Myers -- ejects subordinate Will Ferrell into a fiery pit over his unhappiness with the new painkiller’s packaging and comes up with several aggressive marketing ideas. The video was made for a 2007 annual sales conference.The case is In Re Opioid Litigation, Index no. 40000/2017, Supreme Court of New York, Suffolk County.","news_type":1,"symbols_score_info":{"TEVA":0.9}},"isVote":1,"tweetType":1,"viewCount":1967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003158535,"gmtCreate":1640913684006,"gmtModify":1676533554117,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102463477609770","authorIdStr":"4102463477609770"},"themes":[],"htmlText":"Amazing&nbsp;","listText":"Amazing&nbsp;","text":"Amazing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003158535","repostId":"2195928314","repostType":4,"isVote":1,"tweetType":1,"viewCount":2798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9003158535,"gmtCreate":1640913684006,"gmtModify":1676533554117,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4102463477609770","idStr":"4102463477609770"},"themes":[],"htmlText":"Amazing&nbsp;","listText":"Amazing&nbsp;","text":"Amazing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003158535","repostId":"2195928314","repostType":4,"isVote":1,"tweetType":1,"viewCount":2798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001103090,"gmtCreate":1641179507836,"gmtModify":1676533579944,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4102463477609770","idStr":"4102463477609770"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001103090","repostId":"1135044066","repostType":4,"repost":{"id":"1135044066","kind":"news","pubTimestamp":1641178156,"share":"https://ttm.financial/m/news/1135044066?lang=en_US&edition=fundamental","pubTime":"2022-01-03 10:49","market":"us","language":"en","title":"2022 Could Be a Make-or-Break Year for Lucid Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1135044066","media":"InvestorPlace","summary":"LCID stock is likely to remain volatile as the EV maker attempts to become a key contender","content":"<div>\n<p>Electric vehicle startup Lucid Group(NASDAQ:LCID) has seen some wild swings in recent months. Between mid-October and mid-November, LCID stock more than doubled in price before quickly reversing and ...</p>\n\n<a href=\"https://investorplace.com/2021/12/2022-could-be-a-make-or-break-year-for-lcid-stock/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2022 Could Be a Make-or-Break Year for Lucid Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2022 Could Be a Make-or-Break Year for Lucid Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 10:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/2022-could-be-a-make-or-break-year-for-lcid-stock/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Electric vehicle startup Lucid Group(NASDAQ:LCID) has seen some wild swings in recent months. Between mid-October and mid-November, LCID stock more than doubled in price before quickly reversing and ...</p>\n\n<a href=\"https://investorplace.com/2021/12/2022-could-be-a-make-or-break-year-for-lcid-stock/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc"},"source_url":"https://investorplace.com/2021/12/2022-could-be-a-make-or-break-year-for-lcid-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135044066","content_text":"Electric vehicle startup Lucid Group(NASDAQ:LCID) has seen some wild swings in recent months. Between mid-October and mid-November, LCID stock more than doubled in price before quickly reversing and falling more than 30% into its early December low.The sell-off included an 18% single-day drop on news the U.S. Securities and Exchange Commission was investigating Lucid’s special purpose acquisition company merger.Yet, many believe the company is about to become akey contender in the EV race. It has already started mass production, made initial customer deliveries and is expanding its manufacturing plant.So, as we head into the new year, investors are wondering what’s in store for LCID stock.EV SPACs Under PressureLucid Group made its public debut in late July via a reverse merger with SPAC Churchill Capital Corp IV. Amid the growing EV hype, the initial public offering raised an impressive $4.4 billion in cash.However, in recent months, the SEC has been investigating the SPAC mergers of a number of EV companies. In addition to Lucid, other companies caught in the SEC’s crosshairs include Lordstown Motors(NASDAQ:RIDE),Canoo(NASDAQ:GOEV) and Nikola(NASDAQ:NKLA).As a result, shares of these EV startups have come under pressure in recent weeks. December was also a down month for a number of exchange-traded funds that focus on SPACs. For instance, the Defiance Next Gen SPAC Derived ETF(NYSEARCA:SPAK) lost about 9% for the month.Despite the recent slump, LCID stock has returned more than 50% since going public in late July. And the EV market represents a huge growth opportunity.According toBloombergNEF, the number of EVs sold worldwide this year is expected to nearly double from 2020, hitting a record 6.3 million units. Looking ahead, the Organization of Petroleum Exporting Countries predicted in its 2045 oil outlook that there will be close to 500 million EVs on the road by 2045, accounting for nearly a fifth of the global fleet.Lucid Faces Several ChallengesLCID reported third-quarter results on Nov 15. Revenue came in at $232,000, down 30.5% from the prior-year quarter, while the net loss totaled $524.4 million. However, the company did end the quarter with a nice cash position of $4.8 billion.As of mid-November, Lucid had received over 17,000 reservations for its Lucid Air sedan. To meet demand, management is expanding production capacity at its Arizona plant by adding 2.85 million square feet of space. Lucid aims to manufacture 20,000 EVs next yearand a total of90,000 vehicles by the end of 2023, including new models such as its first SUV, the Gravity.Although investors have been excited about Lucid’s growth prospects, the EV space is highly competitive. In addition to EV darlings like Tesla(NASDAQ:TSLA) and Nio(NYSE:NIO), legacy automakers such as Ford Motor(NYSE:F) and General Motors(NYSE:GM) are making significant inroads in the EV space.Given the recent SEC investigation, as well as the lack of a clear path to profitability, Lucid faces several challenges. The transition period from prototypes to commercial production is typically rife with risks, which could lead to volatility in LCID stock.Thus, a pullback toward $35 or even below could make a better entry point for growth investors.2 Alternative Ways to Invest in LCID StockFor investors who are interested in LCID stock but looking for a way to reduce risk, allow me to pose two alternative strategies.First, there are a number of ETFs that provide exposure to LCID stock, including the iShares MSCI USA Size Factor ETF(NYSEARCA:SIZE),VanEck Low Carbon Energy ETF(NYSEARCA:SMOG) and Vanguard Mid-Cap Value Index Fund ETF Shares(NYSEARCA:VOE).Those readers who are experienced in options could also consider selling cash-secured puts. This strategy may be appropriate if you are slightly bullish or neutral on LCID stock at this time.Selling cash-secured put options generates income as the seller receives a premium. As I write, LCID stock is trading around $38.30. If you sold the $38 strike put that expires on Jan. 21, you could collect about $2.65 in premium. Therefore, the maximum return for the seller on the day of expiry would be $265, excluding trading commissions and costs, if the option expires worthless.If the put option is in the money (meaning LCID stock is lower than the strike price of $38) any time before or at expiration on Jan. 21, this put option can be assigned. The seller would then be obligated to buy 100 shares of LCID stock at the put option strike price of $38 for a total of $3,800 per contract. In that case, the trader ends up owning LCID stock for $35.35 per share, about 8% below the current price.If the put seller gets assigned shares, the maximum risk is similar to that of stock ownership (the stock could theoretically fall to zero) but partially offset by the premium received ($265).The Bottom Line on LCID StockAs I mentioned above,many believe Lucid will become a top contender in the EV race. Its Lucid Air was named the 2022 MotorTrend Car of the Year, an honor bestowed on Tesla’s Model S in 2012.In another sign that bodes well for the EV maker’s exposure and legitimacy, LCID stock wasadded to the Nasdaq 100 index on Dec. 13. And the company recently raised $2.6 billion from a “greenshoeoption” under the convertible senior notes offering, increasing liquidity.On the one hand, Lucid has plans for a broad product range from luxury SUVs to cheaper EVs and the cash buffer to carry out those plans. On the other hand, it faces commercial risks such as production delays, semiconductor shortage-related disruptions and slowing economic growth.Therefore, investors should keep an eye on the sentiment and consider buying LCID stock on a dip or employing an alternative strategy like selling puts or purchasing an ETF to gain exposure to the EV maker.","news_type":1,"symbols_score_info":{"LCID":0}},"isVote":1,"tweetType":1,"viewCount":3019,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001103315,"gmtCreate":1641179543862,"gmtModify":1676533579944,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4102463477609770","idStr":"4102463477609770"},"themes":[],"htmlText":"Not bad","listText":"Not bad","text":"Not bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001103315","repostId":"2200443647","repostType":4,"repost":{"id":"2200443647","kind":"news","pubTimestamp":1641175008,"share":"https://ttm.financial/m/news/2200443647?lang=en_US&edition=fundamental","pubTime":"2022-01-03 09:56","market":"us","language":"en","title":"These are the top 3 stocks to watch in 2022: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2200443647","media":"Yahoo Finance","summary":"Investors should keep an eye out for casino and real estate stocks next year, according to Gerber Ka","content":"<html><head></head><body><p>Investors should keep an eye out for casino and real estate stocks next year, according to Gerber Kawasaki Wealth &amp; Investment Management CEO Ross Gerber.</p><p>MGM (MGM), Lennar (LEN), and Tesla (TSLA) were selected as the top three stocks poised to rise in 2022 in Gerber’s preview. He joined Yahoo Finance Live on Thursday to discuss which stocks should perform best next year.</p><p>“MGM is a long-term holding of ours and we&#39;ve been adding to it on the weakness because of Omicron,” Gerber said. “And we absolutely believe this is the endgame for Corona, this winter being sort of one of the tougher winters again. But as each winter rolls on, this will become much more normal and much less disruptive.”</p><p>MGM Resorts International, a giant in the hospitality and entertainment industry, specializes in casinos, hotels, and resorts. As the global outlook continues to improve and the economy adjusts to the new realities concerning COVID, Gerber noted, the hospitality sector could stand to benefit greatly.</p><p>The prospect of interest rate hikes in 2022 looms over the economic picture for next year and has dampened some analysts’ expectations for stock market growth. “The probability of a 10% correction in the near term or over the next 12 months is elevated,” Bank of America’s (BAC) U.S. stock and quantitative strategy chief Savita Subramanian told Bloomberg earlier this month.</p><p>Gerber, who expressed doubt that all three Fed rate hikes would come in 2022, had a more optimistic disposition.</p><p>“We actually don&#39;t think the Fed will actually hit their three rate hikes next year, we&#39;ll see,” he said. “But if it does happen, it won&#39;t be till the end of the year, and so housing is a supply and demand imbalance on a massive scale. And home builders like Lennar, especially Lennar, which is a really large, established home builder in multiple regions, are just benefiting from this enormous demand. So every house they&#39;re building, the profits just go up every month because prices keep going up.”</p><p>Lennar, a Florida-based home construction company, has suffered recently from supply chain disruptions related to the pandemic. However, industry experts expect many of these challenges within the housing market to be overcome next year. Research and Markets reported that the U.S. construction industry is expected to grow by 3.7% in 2022.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8038b8b290f38bd18329917959e39f73\" tg-width=\"6000\" tg-height=\"4000\" width=\"100%\" height=\"auto\"/><span>NEWARK, CALIFORNIA - DECEMBER 15: A worker makes repairs to a home under construction at the Lennar Bridgeway home development on December 15, 2021 in Newark, California. Homebuilder Lennar will report fourth quarter earnings today after the closing bell. (Photo by Justin Sullivan/Getty Images)Justin Sullivan via Getty Images</span></p><p>Throughout most of the year, the housing market has remained hot. Similar to other industries, like electronics, housing has faced supply bottlenecks and labor shortages which have restricted supply in the face of rising demand. The Federal Housing Finance Agency reported that housing prices grew 18.5% through 2021 Q3 compared to a year ago, culminating in the largest annual increase in the agency’s House Price Index.</p><p><img src=\"https://static.tigerbbs.com/125965aa9230614070fe2f36dbe141ba\" tg-width=\"819\" tg-height=\"688\" width=\"100%\" height=\"auto\"/></p><p>Tesla was Gerber’s last recommendation, and his number one pick for investors in 2022. He had some bold predictions for the EV maker in his interview with Yahoo Finance Live.</p><p>“I think over the next decade, Tesla will be the most consequential company in the history of business,” Gerber said. “I think in 12 months, we&#39;re going to see amazing breakthroughs in AI and technology. And what Elon has done yet, we don&#39;t know, you want to own stock in this future. So with robotics, AI, and the dominance in the EV and climate space, Tesla is the best stock of all time.”</p><p>Tesla certainly rewarded bullish investors in 2021. This year, Tesla stock has gained 56%, more than double the S&amp;P 500’s 27% rise.</p><p>Even so, challenges remain. The company recalled nearly half a million of its Model 3 and Model S over safety issues concerning the cars’ rear view cameras and trunk. Industry experts have raised concerns regarding the sustainability of Tesla’s high market share in the EV market, as well as the possible emergence of competitors.</p><p>Gerber cautioned investors not to be too concerned about the recalls. Recalls are relatively normal for car companies, and Tesla’s main strengths lay outside of their automobile services, anyway, he added.</p><p>“Tesla is a better AI technology company than a car company, as we&#39;ve all learned over the last 10 years,” he said. “They build cars, but they&#39;re basically building an iPhone on wheels. And so the entire infrastructure that they&#39;ve been building around service, for example, has been a big challenge for them. They&#39;ve innovated some amazing things like mobile service.”</p><p>Overall, stocks stayed flat on the final trading day of 2021, giving this year’s Santa Claus Rally a rather muted finish. The S&amp;P 500 reached an intraday high Thursday but fell in the afternoon. This year, the index reached a record high every month, a feat achieved only once before, in 2014.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These are the top 3 stocks to watch in 2022: Analyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese are the top 3 stocks to watch in 2022: Analyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 09:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/top-3-stocks-to-watch-in-2022-analyst-171050141.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors should keep an eye out for casino and real estate stocks next year, according to Gerber Kawasaki Wealth & Investment Management CEO Ross Gerber.MGM (MGM), Lennar (LEN), and Tesla (TSLA) were...</p>\n\n<a href=\"https://finance.yahoo.com/news/top-3-stocks-to-watch-in-2022-analyst-171050141.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4527":"明星科技股","BK4553":"喜马拉雅资本持仓","LEN":"莱纳建筑公司","BAC":"美国银行","BK4099":"汽车制造商","BK4534":"瑞士信贷持仓","BK4555":"新能源车","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4150":"赌场与赌博","BK4504":"桥水持仓","MGM":"美高梅","BK4559":"巴菲特持仓","BK4088":"住宅建筑","BK4550":"红杉资本持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","BK4207":"综合性银行","TSLA":"特斯拉","BK4561":"索罗斯持仓"},"source_url":"https://finance.yahoo.com/news/top-3-stocks-to-watch-in-2022-analyst-171050141.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200443647","content_text":"Investors should keep an eye out for casino and real estate stocks next year, according to Gerber Kawasaki Wealth & Investment Management CEO Ross Gerber.MGM (MGM), Lennar (LEN), and Tesla (TSLA) were selected as the top three stocks poised to rise in 2022 in Gerber’s preview. He joined Yahoo Finance Live on Thursday to discuss which stocks should perform best next year.“MGM is a long-term holding of ours and we've been adding to it on the weakness because of Omicron,” Gerber said. “And we absolutely believe this is the endgame for Corona, this winter being sort of one of the tougher winters again. But as each winter rolls on, this will become much more normal and much less disruptive.”MGM Resorts International, a giant in the hospitality and entertainment industry, specializes in casinos, hotels, and resorts. As the global outlook continues to improve and the economy adjusts to the new realities concerning COVID, Gerber noted, the hospitality sector could stand to benefit greatly.The prospect of interest rate hikes in 2022 looms over the economic picture for next year and has dampened some analysts’ expectations for stock market growth. “The probability of a 10% correction in the near term or over the next 12 months is elevated,” Bank of America’s (BAC) U.S. stock and quantitative strategy chief Savita Subramanian told Bloomberg earlier this month.Gerber, who expressed doubt that all three Fed rate hikes would come in 2022, had a more optimistic disposition.“We actually don't think the Fed will actually hit their three rate hikes next year, we'll see,” he said. “But if it does happen, it won't be till the end of the year, and so housing is a supply and demand imbalance on a massive scale. And home builders like Lennar, especially Lennar, which is a really large, established home builder in multiple regions, are just benefiting from this enormous demand. So every house they're building, the profits just go up every month because prices keep going up.”Lennar, a Florida-based home construction company, has suffered recently from supply chain disruptions related to the pandemic. However, industry experts expect many of these challenges within the housing market to be overcome next year. Research and Markets reported that the U.S. construction industry is expected to grow by 3.7% in 2022.NEWARK, CALIFORNIA - DECEMBER 15: A worker makes repairs to a home under construction at the Lennar Bridgeway home development on December 15, 2021 in Newark, California. Homebuilder Lennar will report fourth quarter earnings today after the closing bell. (Photo by Justin Sullivan/Getty Images)Justin Sullivan via Getty ImagesThroughout most of the year, the housing market has remained hot. Similar to other industries, like electronics, housing has faced supply bottlenecks and labor shortages which have restricted supply in the face of rising demand. The Federal Housing Finance Agency reported that housing prices grew 18.5% through 2021 Q3 compared to a year ago, culminating in the largest annual increase in the agency’s House Price Index.Tesla was Gerber’s last recommendation, and his number one pick for investors in 2022. He had some bold predictions for the EV maker in his interview with Yahoo Finance Live.“I think over the next decade, Tesla will be the most consequential company in the history of business,” Gerber said. “I think in 12 months, we're going to see amazing breakthroughs in AI and technology. And what Elon has done yet, we don't know, you want to own stock in this future. So with robotics, AI, and the dominance in the EV and climate space, Tesla is the best stock of all time.”Tesla certainly rewarded bullish investors in 2021. This year, Tesla stock has gained 56%, more than double the S&P 500’s 27% rise.Even so, challenges remain. The company recalled nearly half a million of its Model 3 and Model S over safety issues concerning the cars’ rear view cameras and trunk. Industry experts have raised concerns regarding the sustainability of Tesla’s high market share in the EV market, as well as the possible emergence of competitors.Gerber cautioned investors not to be too concerned about the recalls. Recalls are relatively normal for car companies, and Tesla’s main strengths lay outside of their automobile services, anyway, he added.“Tesla is a better AI technology company than a car company, as we've all learned over the last 10 years,” he said. “They build cars, but they're basically building an iPhone on wheels. And so the entire infrastructure that they've been building around service, for example, has been a big challenge for them. They've innovated some amazing things like mobile service.”Overall, stocks stayed flat on the final trading day of 2021, giving this year’s Santa Claus Rally a rather muted finish. The S&P 500 reached an intraday high Thursday but fell in the afternoon. This year, the index reached a record high every month, a feat achieved only once before, in 2014.","news_type":1,"symbols_score_info":{"BAC":1,"TSLA":1,"MGM":1,"LEN":0.9}},"isVote":1,"tweetType":1,"viewCount":1859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001109482,"gmtCreate":1641179490977,"gmtModify":1676533579936,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4102463477609770","idStr":"4102463477609770"},"themes":[],"htmlText":"Fantastic&nbsp;","listText":"Fantastic&nbsp;","text":"Fantastic","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001109482","repostId":"2200403714","repostType":4,"isVote":1,"tweetType":1,"viewCount":1789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001103975,"gmtCreate":1641179529100,"gmtModify":1676533579951,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4102463477609770","idStr":"4102463477609770"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001103975","repostId":"2200283644","repostType":4,"repost":{"id":"2200283644","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641175222,"share":"https://ttm.financial/m/news/2200283644?lang=en_US&edition=fundamental","pubTime":"2022-01-03 10:00","market":"us","language":"en","title":"China Evergrande shares to halt trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2200283644","media":"Reuters","summary":"HONG KONG (Reuters) - China Evergrande Group said its shares will be suspended from trading on Monda","content":"<html><head></head><body><p>HONG KONG (Reuters) - China Evergrande Group said its shares will be suspended from trading on Monday, without giving any reason.</p><p>The embattled property developer has more than $300 billion in liabilities and is scrambling to raise cash by selling assets and shares to repay suppliers and creditors.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Evergrande shares to halt trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Evergrande shares to halt trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-03 10:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>HONG KONG (Reuters) - China Evergrande Group said its shares will be suspended from trading on Monday, without giving any reason.</p><p>The embattled property developer has more than $300 billion in liabilities and is scrambling to raise cash by selling assets and shares to repay suppliers and creditors.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4124":"机动车零配件与设备","BK1240":"房地产开发","BK1598":"恒大概念","BK1507":"粤港澳大湾区","BK1555":"内房股","03333":"中国恒大"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200283644","content_text":"HONG KONG (Reuters) - China Evergrande Group said its shares will be suspended from trading on Monday, without giving any reason.The embattled property developer has more than $300 billion in liabilities and is scrambling to raise cash by selling assets and shares to repay suppliers and creditors.","news_type":1,"symbols_score_info":{"03333":1}},"isVote":1,"tweetType":1,"viewCount":1507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003158743,"gmtCreate":1640913705849,"gmtModify":1676533554094,"author":{"id":"4102463477609770","authorId":"4102463477609770","name":"7d4153fd","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4102463477609770","idStr":"4102463477609770"},"themes":[],"htmlText":"Unpredictable&nbsp;","listText":"Unpredictable&nbsp;","text":"Unpredictable","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003158743","repostId":"1175474428","repostType":4,"repost":{"id":"1175474428","kind":"news","pubTimestamp":1640912453,"share":"https://ttm.financial/m/news/1175474428?lang=en_US&edition=fundamental","pubTime":"2021-12-31 09:00","market":"us","language":"en","title":"Teva, Units Held Liable for Fueling N.Y. Opioid Crisis","url":"https://stock-news.laohu8.com/highlight/detail?id=1175474428","media":"Bloomberg","summary":"(Bloomberg) -- New York jurors concluded Teva Pharmaceutical Industries and some of its units helped","content":"<html><head></head><body><p>(Bloomberg) -- New York jurors concluded Teva Pharmaceutical Industries and some of its units helped create a public-health crisis through their marketing and distribution of opioid painkillers across the state, in the pharma industry’s latest loss in the sprawling litigation over the highly addictive drugs.</p><p>The Israel-based firm now faces potentially billions of dollars in compensation claims from the state and two Long Island counties accusing Teva executives of flooding their areas with more than a billion opioids pills over nearly a decade and using misleading tactics to sell them.</p><p>Teva’s American depository receipts fell as much as 5.3% in New York trading, the most intraday since Nov. 3.</p><p>“Teva Pharmaceuticals strongly disagrees with today’s outcome and will prepare for a swift appeal,” Kelley Dougherty, a U.S.-based spokeswoman for Teva, said in an emailed statement. The state and local governments “presented no evidence of medically unnecessary prescriptions, suspicious or diverted orders, no evidence of oversupply by the defendants” and also failed to show “any harm to the public in the state,” she said.</p><p>Judge Jerry Garguilo will decide later how much the state and counties should get to beef up treatment and social-service budgets depleted by the U.S. opioid crisis, which has killed more than 500,000 Americans over the last two decades. A hearing on the compensation issue hasn’t yet been set.</p><p><b>‘Death and Destruction’</b></p><p>Jurors found Teva itself was 30% liable for harm created by its opioid marketing in Suffolk and Nassau counties while it was 40% liable for the problems across the whole state. Its units’ percentages of fault made up the remainder of 100%, according to the verdict form.</p><p>“A jury has found an opioid manufacturer responsible for the death and destruction they inflicted on the American people,” New York Attorney General Letitia James said in an emailed statement. “Teva Pharmaceuticals USA and others misled the American people about the true dangers of opioids.”</p><p>Jayne Conroy, one of the counties’ lawyers, noted the jurors deliberated for more than a week before finding against Teva and its units. She said the panel properly found “manufacturer Teva and distributor Anda cannot break the law for profit and cause deadly harm to our communities.”</p><p>Lawyers for Teva and Anda on Thursday asked Garguilo to throw out the verdict, saying the state and counties didn’t prove the companies created a public nuisance. They also pointed to the inconsistency in the percentage of fault Teva faces in the verdicts on behalf of the counties and the state as warranting a new trial.</p><p><b>Second Verdict</b></p><p>Thursday’s jury verdict is the second in the burgeoning four-year opioid litigation. Municipalities accuse opioid makers, distributors and sellers of downplaying the painkillers’ addiction risks and sacrificing patient safety for billions in profits. They also blame them for contributing to the deaths of more than 500,000 Americans in the opioid epidemic over the last two decades.</p><p>The state-court jury found Teva and subsidiaries including Anda Inc. and Cephalon Inc. created a so-called “public nuisance” by marketing the opioid-based drugs in a misleading manner and not properly monitoring suspicious shipments of the highly addictive painkillers. The panel concluded the marketing “contributed to, or maintained a substantial and unreasonable interference with a public right that amounts to a public nuisance,” according to the verdict form.</p><p>The trial over the governments’ claims began in June with more than 30 companies as defendants. By the end, only Teva and its units, including Cephalon Inc., Actavis Pharma and Watson Laboratories Inc., were left to face the six-person jury. That’s because other opioid makers, including Johnson &amp; Johnson and Endo International Plc, drug distributors such as McKesson Corp. and Cardinal Health Inc. drugstore chains like Rite Aid Inc. and Walgreens Boots Alliance Inc., settled to get out of the trial.</p><p>The six-month trial, held in Suffolk County on Long Island, featured internal sales-conference videos produced by Cephalon that the governments alleged showed the company pushed opioid sales to beef up bonuses and put profit over consumers’ safety.</p><p><b>Dr. Evil</b></p><p>The panel saw a 2006 video based on a scene from the 1992 film “A Few Good Men,” that the Teva subsidiary used at a sales conference to promote its opioid-based drug, Fentora.</p><p>Dressed in a Marine uniform, Roy Craig, a Cephalon sales manager, portrays Jack Nicholson’s character in the movie. “I have neither the time nor the inclination to explain ourselves to people who rise and sleep under the very blanket of revenue we provide and then question the manner in which we provide it,” Craig says on the video.</p><p>Lawyers for the governments also showed jurors a dubbed parody of the 1997 “Austin Powers, International Man of Mystery” movie in which the villain, Dr. Evil, portrays a Cephalon sales executive leading a Fentora marketing meeting.</p><p>Dr. Evil -- played by actor Michael Myers -- ejects subordinate Will Ferrell into a fiery pit over his unhappiness with the new painkiller’s packaging and comes up with several aggressive marketing ideas. The video was made for a 2007 annual sales conference.</p><p>The case is In Re Opioid Litigation, Index no. 40000/2017, Supreme Court of New York, Suffolk County.</p></body></html>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teva, Units Held Liable for Fueling N.Y. Opioid Crisis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeva, Units Held Liable for Fueling N.Y. Opioid Crisis\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pharmaceutical-company-held-liable-fuelling-182732417.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- New York jurors concluded Teva Pharmaceutical Industries and some of its units helped create a public-health crisis through their marketing and distribution of opioid painkillers across...</p>\n\n<a href=\"https://finance.yahoo.com/news/pharmaceutical-company-held-liable-fuelling-182732417.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TEVA":"梯瓦制药"},"source_url":"https://finance.yahoo.com/news/pharmaceutical-company-held-liable-fuelling-182732417.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175474428","content_text":"(Bloomberg) -- New York jurors concluded Teva Pharmaceutical Industries and some of its units helped create a public-health crisis through their marketing and distribution of opioid painkillers across the state, in the pharma industry’s latest loss in the sprawling litigation over the highly addictive drugs.The Israel-based firm now faces potentially billions of dollars in compensation claims from the state and two Long Island counties accusing Teva executives of flooding their areas with more than a billion opioids pills over nearly a decade and using misleading tactics to sell them.Teva’s American depository receipts fell as much as 5.3% in New York trading, the most intraday since Nov. 3.“Teva Pharmaceuticals strongly disagrees with today’s outcome and will prepare for a swift appeal,” Kelley Dougherty, a U.S.-based spokeswoman for Teva, said in an emailed statement. The state and local governments “presented no evidence of medically unnecessary prescriptions, suspicious or diverted orders, no evidence of oversupply by the defendants” and also failed to show “any harm to the public in the state,” she said.Judge Jerry Garguilo will decide later how much the state and counties should get to beef up treatment and social-service budgets depleted by the U.S. opioid crisis, which has killed more than 500,000 Americans over the last two decades. A hearing on the compensation issue hasn’t yet been set.‘Death and Destruction’Jurors found Teva itself was 30% liable for harm created by its opioid marketing in Suffolk and Nassau counties while it was 40% liable for the problems across the whole state. Its units’ percentages of fault made up the remainder of 100%, according to the verdict form.“A jury has found an opioid manufacturer responsible for the death and destruction they inflicted on the American people,” New York Attorney General Letitia James said in an emailed statement. “Teva Pharmaceuticals USA and others misled the American people about the true dangers of opioids.”Jayne Conroy, one of the counties’ lawyers, noted the jurors deliberated for more than a week before finding against Teva and its units. She said the panel properly found “manufacturer Teva and distributor Anda cannot break the law for profit and cause deadly harm to our communities.”Lawyers for Teva and Anda on Thursday asked Garguilo to throw out the verdict, saying the state and counties didn’t prove the companies created a public nuisance. They also pointed to the inconsistency in the percentage of fault Teva faces in the verdicts on behalf of the counties and the state as warranting a new trial.Second VerdictThursday’s jury verdict is the second in the burgeoning four-year opioid litigation. Municipalities accuse opioid makers, distributors and sellers of downplaying the painkillers’ addiction risks and sacrificing patient safety for billions in profits. They also blame them for contributing to the deaths of more than 500,000 Americans in the opioid epidemic over the last two decades.The state-court jury found Teva and subsidiaries including Anda Inc. and Cephalon Inc. created a so-called “public nuisance” by marketing the opioid-based drugs in a misleading manner and not properly monitoring suspicious shipments of the highly addictive painkillers. The panel concluded the marketing “contributed to, or maintained a substantial and unreasonable interference with a public right that amounts to a public nuisance,” according to the verdict form.The trial over the governments’ claims began in June with more than 30 companies as defendants. By the end, only Teva and its units, including Cephalon Inc., Actavis Pharma and Watson Laboratories Inc., were left to face the six-person jury. That’s because other opioid makers, including Johnson & Johnson and Endo International Plc, drug distributors such as McKesson Corp. and Cardinal Health Inc. drugstore chains like Rite Aid Inc. and Walgreens Boots Alliance Inc., settled to get out of the trial.The six-month trial, held in Suffolk County on Long Island, featured internal sales-conference videos produced by Cephalon that the governments alleged showed the company pushed opioid sales to beef up bonuses and put profit over consumers’ safety.Dr. EvilThe panel saw a 2006 video based on a scene from the 1992 film “A Few Good Men,” that the Teva subsidiary used at a sales conference to promote its opioid-based drug, Fentora.Dressed in a Marine uniform, Roy Craig, a Cephalon sales manager, portrays Jack Nicholson’s character in the movie. “I have neither the time nor the inclination to explain ourselves to people who rise and sleep under the very blanket of revenue we provide and then question the manner in which we provide it,” Craig says on the video.Lawyers for the governments also showed jurors a dubbed parody of the 1997 “Austin Powers, International Man of Mystery” movie in which the villain, Dr. Evil, portrays a Cephalon sales executive leading a Fentora marketing meeting.Dr. Evil -- played by actor Michael Myers -- ejects subordinate Will Ferrell into a fiery pit over his unhappiness with the new painkiller’s packaging and comes up with several aggressive marketing ideas. The video was made for a 2007 annual sales conference.The case is In Re Opioid Litigation, Index no. 40000/2017, Supreme Court of New York, Suffolk County.","news_type":1,"symbols_score_info":{"TEVA":0.9}},"isVote":1,"tweetType":1,"viewCount":1967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}